Özdemiral, C. Et Al. 2024. Allergen-specific immunotherapy at the extremes of age: below 5 years and elderly: evidence beyond indications?. Current opinion in allergy and clinical immunology , vol.24 , 510-519.

Özdemiral, C., Gurel, D., & Sahiner, Ü. M., (2024). Allergen-specific immunotherapy at the extremes of age: below 5 years and elderly: evidence beyond indications?. Current opinion in allergy and clinical immunology , vol.24, 510-519.

Özdemiral, Cansu, DENİZ İLGÜN GÜREL, And ÜMİT MURAT ŞAHİNER. "Allergen-specific immunotherapy at the extremes of age: below 5 years and elderly: evidence beyond indications?," Current opinion in allergy and clinical immunology , vol.24, 510-519, 2024

Özdemiral, Cansu Et Al. "Allergen-specific immunotherapy at the extremes of age: below 5 years and elderly: evidence beyond indications?." Current opinion in allergy and clinical immunology , vol.24, pp.510-519, 2024

Özdemiral, C. Gurel, D. And Sahiner, Ü. M. (2024) . "Allergen-specific immunotherapy at the extremes of age: below 5 years and elderly: evidence beyond indications?." Current opinion in allergy and clinical immunology , vol.24, pp.510-519.

@article{article, author={Cansu Özdemiral Et Al. }, title={Allergen-specific immunotherapy at the extremes of age: below 5 years and elderly: evidence beyond indications?}, journal={Current opinion in allergy and clinical immunology}, year=2024, pages={510-519} }